We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
Cap. Flow
+$798M
Cap. Flow %
0.98%
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$65.3M
2
AMZN icon
Amazon
AMZN
+$50M
3
TSLA icon
Tesla
TSLA
+$30.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.6M
5
EPAM icon
EPAM Systems
EPAM
+$26.3M

Sector Composition

Rank Sector Weight
1 Technology 25.54%
2 Financials 13.15%
3 Healthcare 12.95%
4 Consumer Discretionary 12.27%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TITN icon
2226
Titan Machinery
TITN
$445M
$974K ﹤0.01%
28,907
+49
+0.2% +$1.52K
CNR
2227
DELISTED
Cornerstone Building Brands, Inc.
CNR
$973K ﹤0.01%
55,802
-351
-0.6% -$5.45K
REAL icon
2228
The RealReal
REAL
$1.5B
$969K ﹤0.01%
83,505
-524
-0.6% -$6.89K
GSBC icon
2229
Great Southern Bancorp
GSBC
$878M
$966K ﹤0.01%
16,310
-461
-3% -$26.5K
HYLN icon
2230
Hyliion Holdings
HYLN
$690M
$965K ﹤0.01%
155,598
-661
-0.4% -$4.72K
LEN.B icon
2231
Lennar Class B
LEN.B
$20.8B
$963K ﹤0.01%
10,592
+438
+4% +$36K
DM
2232
DELISTED
Desktop Metal, Inc.
DM
$962K ﹤0.01%
19,432
+4,624
+31% +$311K
ARKO icon
2233
ARKO Corp
ARKO
$635M
$956K ﹤0.01%
109,045
+1,657
+2% +$15.9K
MXCT icon
2234
MaxCyte
MXCT
$126M
$955K ﹤0.01%
93,694
+82,957
+773% +$891K
CNA icon
2235
CNA Financial
CNA
$14.1B
$948K ﹤0.01%
21,515
+476
+2% +$21.2K
HTBK
2236
DELISTED
Heritage Commerce
HTBK
$945K ﹤0.01%
79,141
-389
-0.5% -$4.54K
ERII icon
2237
Energy Recovery
ERII
$443M
$942K ﹤0.01%
43,829
-784
-2% -$16.4K
MGI
2238
DELISTED
MoneyGram International, Inc. New
MGI
$942K ﹤0.01%
119,378
+4,120
+4% +$28.3K
HRTX icon
2239
Heron Therapeutics
HRTX
$92.9M
$941K ﹤0.01%
103,098
-1,941
-2% -$19.8K
RCKT icon
2240
Rocket Pharmaceuticals
RCKT
$394M
$940K ﹤0.01%
43,077
-1,319
-3% -$36K
SENEA icon
2241
Seneca Foods Class A
SENEA
$1.21B
$932K ﹤0.01%
19,433
+23
+0.1% +$1.13K
FMBH icon
2242
First Mid Bancshares
FMBH
$1.36B
$931K ﹤0.01%
21,760
-302
-1% -$12.9K
FA icon
2243
First Advantage
FA
$4.12B
$928K ﹤0.01%
48,714
+23,330
+92% +$449K
NRIX icon
2244
Nurix Therapeutics
NRIX
$2.65B
$925K ﹤0.01%
31,938
+864
+3% +$26.2K
MPAA icon
2245
Motorcar Parts of America
MPAA
$258M
$922K ﹤0.01%
54,041
+720
+1% +$13.5K
AGX icon
2246
Argan
AGX
$8.37B
$921K ﹤0.01%
23,808
-271
-1% -$11.3K
RES icon
2247
RPC Inc
RES
$1.3B
$921K ﹤0.01%
202,836
+7,556
+4% +$37.1K
BY icon
2248
Byline Bancorp
BY
$1.76B
$910K ﹤0.01%
33,267
+28
+0.1% +$738
ACBI
2249
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$910K ﹤0.01%
31,629
-356
-1% -$10.1K
CNM icon
2250
Core & Main
CNM
$8.71B
$908K ﹤0.01%
29,916
+10,568
+55% +$290K

Similar funds

RhumbLine Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
  • RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
  • RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
  • RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.

Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.